STERIS is Pleased to Announce Our Brooklyn Park, MN USA Laboratory Now Offers GLP Cytotoxicity Testing

June 1, 2026

  • Supports medical device and pharmaceutical manufacturing with additional biocompatibility testing capabilities
  • Complements existing microbiological, analytical, and product and package testing services offered at Brooklyn Park, MN

As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota laboratory now offers cytotoxicity testing services in accordance with Good Laboratory Practice (GLP).

GLP cytotoxicity testing plays a critical role in evaluating the biocompatibility of medical devices and pharmaceuticals, assessing materials for potential toxicity to living cells.

Our ISO/IEC 17025 accredited cytotoxicity testing services comply with ISO 10993-5 and GLP standards, and complements the laboratory’s existing microbiological, analytical, and product and packaging testing services.

In addition to our Brooklyn Park, Minnesota location, STERIS provides laboratory testing services through a global network that includes facilities in the Americas, Europe, and Asia.

Product release to market is further supported by the STERIS AST global network of contract irradiation and gas sterilization facilities.

Go here to learn more about our comprehensive laboratory testing services.

Cytotoxicity Testing

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. 

WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. 

For more information, visit www.steris.com.

 
Related Posts
April 1, 2026

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS is pleased to announce the completed expansion of its existing Kuala Ketil, Malaysia laboratory.

April 1, 2026

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS is pleased to announce the expansion of its radiation testing services to include a new Radiation Technology Center (RTC) in Kuala Ketil, Malaysia.  

STERIS is Pleased to Announce Our Ede, The Netherlands Laboratory Now Offers EO Residual Testing
March 26, 2026

As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our Ede, The Netherlands laboratory now offers EO residual testing in accordance with ISO 10993-7.